phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with isoleucine in 2 studies
Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (isoleucine) | Trials (isoleucine) | Recent Studies (post-2010) (isoleucine) |
---|---|---|---|---|---|
191 | 4 | 23 | 5,938 | 74 | 1,138 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernardi, F; Camire, RM; High, KA; Marchetti, G; Pinotti, M; Pollak, ES; Tidd, T; Toso, R | 1 |
Aguzzi, MS; Capogrossi, MC; De Cristofaro, R; Facchiano, A; Faraone, D; Giampietri, C; Totta, P | 1 |
2 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and isoleucine
Article | Year |
---|---|
Factor VII mutant V154G models a zymogen-like form of factor VIIa.
Topics: Alanine; Amino Acid Chloromethyl Ketones; Binding Sites; Enzyme Precursors; Factor VII; Factor VIIa; Humans; Isoleucine; Point Mutation; Protein Conformation; Serine Proteinase Inhibitors; Thromboplastin; Valine | 2003 |
Thrombin-mediated impairment of fibroblast growth factor-2 activity.
Topics: Amino Acid Chloromethyl Ketones; Arginine; Binding Sites; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromatography, High Pressure Liquid; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Flow Cytometry; Humans; Hydrolysis; Isoleucine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Protein Binding; Receptors, Thrombin; Thrombin | 2009 |